Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., MRCGP (UK)
Consultant Physician
M.B.B.S., Diploma In Cardiac Rehabilitation, M.C.P.S
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Diabetologist
MBBS, MSc (Epidemiology) (UK), DTM&H (UK), MPH (USA)
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology)
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Consultant Physician
M.D., FCPS (Gastroenterology)
Gastroenterologist
M.B.B.S., FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures